StockWatch
·
ROYAL ORCHID HOTELS LTD. · QQ2 FY-2027 · THE CALL

Strong PAT growth masks margin compression from pre-opening costs

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsROHLTDROYAL ORCHID HOTELS LTD.17 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Hit Q2 PAT (₹14.7 Cr delivered), beat revenue (+39% vs 34% claim). EBITDA lagged QoQ (-3.8%); recurring earnings softer than headline due to Tanzania divestment exceptional gain.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Delivered strong Q2 PAT growth (+243%), beating expectations. But EBITDA down 3.8% QoQ signals margin compression from pre-opening costs and GST disallowance (~₹2 Cr/quarter). ICONIQA at ₹80 Cr annualized (20% below target) remains ramp-stage. Without quantified guidance and facing macro uncertainty, near-term visibility weak.

₹110.1 Cr

Revenue · +39.1% YoY

₹14.7 Cr

Reported PAT · +243.2% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Total income ₹116 Cr, 34% growth

OVERSTATED

Revenue ₹110.1 Cr, 39.1% growth; total income includes other income

EBITDA grew 53% to ₹31.66 Cr

Mixed

EBITDA down 3.8% QoQ despite +2.7% revenue growth

PAT ₹14.73 Cr, up from ₹4.29 Cr (243% growth)

MET

Delivered ₹14.7 Cr, 243.2% growth; includes exceptional gain from Tanzania divestment

ICONIQA revenue ₹20 Cr quarterly, ₹80 Cr annualized

MET

Tracking at ₹80 Cr run rate vs ₹100 Cr target

Managed hotel PBT margins 37-38%

Partial

Analyst extracted ~36% after inter-company adjustments

Earnings quality

What changed since the last call

Deltas vs. the prior call

ICONIQA revenue trajectory

Downgrade

Q2 at ₹20 Cr quarterly = ₹80 Cr annualized; below the ₹100 Cr target cited in prior call. 20% shortfall.

Guidance stance

Neutral

Reiterated 10-12% managed hotel growth, no revenue targets (macro uncertainty). Maintained ₹100 Cr ICONIQA target, Vision 2030 ₹150 Cr fees.

Margin pressure acknowledgment

Downgrade

EBITDA down 3.8% QoQ; management cites pre-opening costs and GST disallowance (~₹2 Cr/quarter) as persistent headwinds persisting into FY28.

The Q&A

Analysts pressed hard on ICONIQA ramp timeline, margin compression, governance red flags (qualified audit, SEBI case). Management held firm on long-term thesis but acknowledged external pressures. Defensive on governance but framed as resolved.

The exchanges that mattered

Managed hotel growth — Chirag Singhal

Partial

10-12% growth this year, potentially higher. Market-dependent on hotel openings and occupancy maturation timing.

Managed hotel margins — Chirag Singhal

Answered

11.5% PBT growth vs prior year. 37-38% operating margins, ~36% after inter-company adjustments.

ICONIQA revenue timeline — Chirag Singhal

Partial

This financial year is the target. Q4 is seasonally strongest; last Q4 did ₹23 Cr. Exact path depends on 50 hotels, timing, occupancy maturation.

EBITDA decline — Misha Dani

Answered

Seasonality, pre-opening costs (Vadodara ₹1-1.5 Cr), new hotel ramp. Expect very good EBITDA going forward.

ICONIQA occupancy — Misha Dani

Partial

No, occupancy has not declined. FY26 was 81%, Q1-Q2 FY27 70%. Seasonally low in Q1-Q2; Q4 is seasonally strongest.

Corporate governance — Vivek Malhotra

Defensive

Strong governance policy; SEBI ruled in company's favor on initial order. Accounting matter pending, final hearing happened, expecting order soon.

GST impact resolution — Rahul Bhangadia

Partial

GST is a persistent issue (₹2 Cr/quarter). Mid-market hotels (ADR <₹7,500) cannot take input credit. Engaging with government. New hotels take 6-12 months to settle.

Guidance

Forward guidance and management's confidence

No formal revenue targets; managed hotels 10-12% growth FY27

Medium

10-15% upper bound cited. Market-dependent on hotel openings and occupancy maturation timing.

EBITDA expected to improve Q3/Q4; long-term 'very good'

Low

Vague; pre-opening costs and GST headwind will persist. No specific margin target stated.

50 hotels, 3,500 rooms in pipeline; asset-light model

Medium

No specific capex amount or timeline. Focus on partnership-driven expansion.

Risks the call surfaced

Ranked by how much they should concern a holder

GST policy

High

₹2 Cr per quarter impact. Mid-market hotels (ADR <₹7,500) cannot take GST input credit on lease/rent (18% GST rate). No resolution timeline from government.

ICONIQA execution

Medium

ICONIQA at ₹80 Cr annualized vs ₹100 Cr target (20% gap). Occupancy 70% (industry avg 75-80%+). Pre-opening costs (Vadodara ₹1-1.5 Cr) pressuring Q2 margins.

Pre-opening costs

Medium

Vadodara property added ₹1-1.5 Cr pre-opening cost in Q2. 50-hotel pipeline will incur similar costs, pressuring near-term margins. Ramp timeline uncertain.

Portfolio execution

Medium

50 hotels (3,500 rooms) in pipeline. No specific timeline stated. Market-dependent (need partners ready, occupancy maturation time).

Corporate governance

Low

Qualified audit opinions for 3 consecutive years. SEBI loss of control order (resolved). Accounting matter pending. Subsidiary loans without repayment schedules.

Macro/demand risk

Medium

Management cites 'war scenario' for not providing forward guidance. Impact on domestic business travel and leisure demand unclear.

Management

Score 6/10. Clear on operational metrics (keys, ARR, occupancy), but vague on forward guidance. Cites macro uncertainty (war) as reason for no revenue targets. Defensive on governance red flags. Delivered Q2 (beat PAT +243%, revenue +39%). But EBITDA margin compression (-3.8% QoQ) and ICONIQA at ₹80 Cr (20% below target) signal slower-than-expected ramp.

What to watch next
  • 1 · Q3-Q4 FY27

    ICONIQA pre-opening costs subside; seasonal strength; ₹25 Cr quarterly target

  • 2 · FY28

    50-hotel pipeline stabilization; Vadodara ramp; managed hotel 10-12% growth

  • 3 · 2030

    Vision: ₹150 Cr management fee target via premiumization and portfolio expansion

Without quantified guidance and facing macro uncertainty, near-term visibility weak.

Informational and educational content only. Not investment advice.

Strong PAT growth masks margin compression from pre-opening costs — StockWatch